Table of Contents
Hepatitis Research and Treatment
Volume 2014 (2014), Article ID 131920, 7 pages
http://dx.doi.org/10.1155/2014/131920
Research Article

Hepatitis B Awareness among Medical Students and Their Vaccination Status at Syrian Private University

1Internal Medicine and Gastroenterology Departments, Syrian Private University, P.O. Box 36822, Damascus, Syria
2Internal Medicine Department, Syrian Private University, Mazzeh Street, P.O. Box 36822, Damascus, Syria

Received 16 May 2014; Revised 23 October 2014; Accepted 23 October 2014; Published 12 November 2014

Academic Editor: Piero Luigi Almasio

Copyright © 2014 Nazir Ibrahim and Amr Idris. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. F. Carman and H. C. Thomas, “Genetic variation in hepatitis B virus,” Gastroenterology, vol. 102, no. 2, pp. 711–719, 1992. View at Google Scholar · View at Scopus
  2. N. Gitlin, “Hepatitis B: diagnosis, prevention, and treatment,” Clinical Chemistry, vol. 43, no. 8, pp. 1500–1506, 1997. View at Google Scholar · View at Scopus
  3. A. J. Zuckerman, “More than third of world's population has been infected with hepatitis B virus,” British Medical Journal, vol. 318, no. 7192, article 1213, 1999. View at Google Scholar · View at Scopus
  4. World Health Organization, “The world health report 1996. Fighing disease. Fostering development,” Executive Summary, World Health Organization, Geneva, Switzerland, 1996. View at Google Scholar
  5. M. J. Alter, “Epidemiology and prevention of hepatitis B,” Seminars in Liver Disease, vol. 23, no. 1, pp. 39–46, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Lavanchy, “Hepatitis B virus epidemiology, disease burden, treatment, arid current and emerging prevention and control measures,” Journal of Viral Hepatitis, vol. 11, no. 2, pp. 97–107, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. Sun, L. Ming, X. Zhu, and J. Lu, “Prevention and control of hepatitis B in China,” Journal of Medical Virology, vol. 67, no. 3, pp. 447–450, 2002. View at Publisher · View at Google Scholar
  8. M. J. Alter, J. Ahtone, I. Weisfuse, K. Starko, T. D. Vacalis, and J. E. Maynard, “Hepatitis B virus transmission between heterosexuals,” The Journal of the American Medical Association, vol. 256, no. 10, pp. 1307–1310, 1986. View at Publisher · View at Google Scholar · View at Scopus
  9. L. A. Kingsley, C. R. Rinaldo Jr., D. W. Lyter, R. O. Valdiserri, S. H. Belle, and M. Ho, “Sexual transmission efficiency of hepatitis B virus and human immunodeficiency virus among homosexual men,” The Journal of the American Medical Association, vol. 264, no. 2, pp. 230–234, 1990. View at Publisher · View at Google Scholar · View at Scopus
  10. R. P. Beasley, C. Trepo, C. E. Stevens II, and W. Szmuness, “The e antigen and vertical transmission of hepatitis B surface antigen,” The American Journal of Epidemiology, vol. 105, no. 2, pp. 94–98, 1977. View at Google Scholar · View at Scopus
  11. A. Kane, J. Lloyd, M. Zaffran, L. Simonsen, and M. Kane, “Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates,” Bulletin of the World Health Organization, vol. 77, no. 10, pp. 801–807, 1999. View at Google Scholar
  12. B. Broers, C. Junet, M. Bourquin, J.-J. Déglon, L. Perrin, and B. Hirschel, “Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995,” AIDS, vol. 12, no. 15, pp. 2059–2066, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Vegnente, R. Iorio, S. Guida, and L. Cimmino, “Chronicity rate of hepatitis B virus infection in the families of 60 hepatitis B surface antigen positive chronic carrier children: role of horizontal transmission,” European Journal of Pediatrics, vol. 151, no. 3, pp. 188–191, 1992. View at Publisher · View at Google Scholar · View at Scopus
  14. J. L. Lauer, N. A. VanDrunen, J. W. Washburn, and H. H. Balfour Jr., “Transmission of hepatitis B virus in clinical laboratory areas,” Journal of Infectious Diseases, vol. 140, no. 4, pp. 513–516, 1979. View at Publisher · View at Google Scholar · View at Scopus
  15. D. J. Hu, M. A. Kane, and D. L. Heymann, “Transmission of HIV, hepatitis B virus, and other bloodborne pathogens in health care settings: a review of risk factors and guidelines for prevention,” Bulletin of the World Health Organization, vol. 69, no. 5, pp. 623–630, 1991. View at Google Scholar · View at Scopus
  16. J. F. Fernandes, R. F. S. Braz, F. A. V. Neto, M. A. Silva, N. F. Costa, and A. M. Ferreira, “Prevalence of serologic markers of hepatitis B virus in hospital personnel,” Revista de Saúde Pública, vol. 33, no. 2, pp. 122–128, 1999. View at Google Scholar
  17. M. Colombo, S. Oldani, M. F. Donato et al., “A multicenter, prospective study of posttransfusion hepatitis in Milan,” Hepatology, vol. 7, no. 4, pp. 709–712, 1987. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Saxena, V. Thakur, B. Sood, R. C. Guptan, S. Gururaja, and S. K. Sarin, “Transfusion-associated hepatitis in a tertiary referral hospital in India. A prospective study,” Vox Sanguinis, vol. 77, no. 1, pp. 6–10, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. S. V. Williams, J. C. Huff, E. J. Feinglass, M. B. Gregg, M. H. Hatch, and J. M. Matsen, “Epidemic viral hepatitis, type B, in hospital personnel,” The American Journal of Medicine, vol. 57, no. 6, pp. 904–911, 1974. View at Publisher · View at Google Scholar · View at Scopus
  20. V. A. Mioli, E. Balestra, L. Bibiano et al., “Epidemiology of viral hepatitis in dialysis centers: a national survey,” Nephron, vol. 61, no. 3, pp. 278–283, 1992. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Prüss-Üstün, E. Rapiti, and Y. Hutin, “Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers,” The American Journal of Industrial Medicine, vol. 48, no. 6, pp. 482–490, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. J. L. Gerberding, “Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study,” Journal of Infectious Diseases, vol. 170, no. 6, pp. 1410–1417, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. World Health Organization, “Global policy report on the prevention and control of viral hepatitis in WHO Member States,” Tech. Rep., World Health Organization, Geneva, Switzerland, 2013. View at Google Scholar
  24. B. J. McMahon, W. L. M. Alward, D. B. Hall et al., “Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state,” Journal of Infectious Diseases, vol. 151, no. 4, pp. 599–603, 1985. View at Publisher · View at Google Scholar · View at Scopus
  25. K. C. Hyams, “Risks of chronicity following acute hepatitis B virus infection: a review,” Clinical Infectious Diseases, vol. 20, no. 4, pp. 992–1000, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Ikeda, S. Saitoh, Y. Suzuki et al., “Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients,” Journal of Hepatology, vol. 28, no. 6, pp. 930–938, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. R. P. Beasley and L. Y. Hwang, “Overview of the epidemiology of hepatocellular carcinoma,” in Viral Hepatitis and Liver Disease: Proceedings of the International Symposium on Viral Hepatitis and Liver Disease: Contemporary Issues and Future Prospects, F. B. Hollinger, S. M. Lemon, and H. S. Margolis, Eds., pp. 532–535, Williams & Wilkins, Baltimore, Md, USA, 1991.
  28. J. F. Perz, G. L. Armstrong, L. A. Farrington, Y. J. F. Hutin, and B. P. Bell, “The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide,” Journal of Hepatology, vol. 45, no. 4, pp. 529–538, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. Hepatitis B Vaccine, Hepatitis B Foundation, Doylestown, Pa, USA, 2009.
  30. S. S. Al Ghamdi, H. I. Fallatah, D. M. Fetyani, J. A. Al-Mughales, and A. T. Gelaidan, “Long-term efficacy of the hepatitis B Vaccine in a high-risk group,” Journal of Medical Virology, vol. 85, no. 9, pp. 1518–1522, 2013. View at Publisher · View at Google Scholar · View at Scopus